Buckingham Strategic Wealth’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $816K | Buy |
13,824
+1,954
| +16% | +$122K | 0.01% | 371 |
|
|
2024
Q1 | $947K | Sell |
11,870
-338
| -3% | -$25.8K | 0.01% | 345 |
|
|
2023
Q4 | $964K | Buy |
12,208
+3,290
| +37% | +$234K | 0.01% | 332 |
|
|
2023
Q3 | $623K | Sell |
8,918
-1,240
| -12% | -$87.9K | 0.01% | 373 |
|
|
2023
Q2 | $702K | Sell |
10,158
-1,549
| -13% | -$110K | 0.01% | 350 |
|
|
2023
Q1 | $1.09M | Hold |
11,707
| – | – | 0.02% | 251 |
|
|
2022
Q4 | $1.09M | Sell |
11,707
-485
| -4% | -$46.8K | 0.02% | 252 |
|
|
2022
Q3 | $1.16M | Sell |
12,192
-211
| -2% | -$20.9K | 0.02% | 239 |
|
|
2022
Q2 | $1.15M | Buy |
12,403
+1,535
| +14% | +$150K | 0.02% | 245 |
|
|
2022
Q1 | $1.1M | Sell |
10,868
-911
| -8% | -$95.7K | 0.02% | 247 |
|
|
2021
Q4 | $1.22M | Sell |
11,779
-411
| -3% | -$38K | 0.02% | 242 |
|
|
2021
Q3 | $1.03M | Buy |
12,190
+1,414
| +13% | +$118K | 0.02% | 250 |
|
|
2021
Q2 | $899K | Buy |
10,776
+2,737
| +34% | +$224K | 0.02% | 261 |
|
|
2021
Q1 | $605K | Buy |
8,039
+1,324
| +20% | +$96.4K | 0.03% | 293 |
|
|
2020
Q4 | $459K | Sell |
6,715
-6,618
| -50% | -$430K | 0.02% | 332 |
|
|
2020
Q3 | $779K | Buy |
13,333
+85
| +0.6% | +$5.29K | 0.06% | 209 |
|
|
2020
Q2 | $861K | Sell |
13,248
-3,641
| -22% | -$229K | 0.08% | 162 |
|
|
2020
Q1 | $1M | Buy |
16,889
+730
| +5% | +$48.7K | 0.1% | 160 |
|
|
2019
Q4 | $1.2M | Buy |
16,159
+805
| +5% | +$56.5K | 0.12% | 139 |
|
|
2019
Q3 | $968K | Buy |
15,354
+885
| +6% | +$52.4K | 0.1% | 146 |
|
|
2019
Q2 | $788K | Sell |
14,469
-252
| -2% | -$13.6K | 0.09% | 172 |
|
|
2019
Q1 | $794K | Buy |
14,721
+3,223
| +28% | +$199K | 0.1% | 163 |
|
|
2018
Q4 | $753K | Buy |
11,498
+1,819
| +19% | +$136K | 0.11% | 146 |
|
|
2018
Q3 | $762K | Buy |
9,679
+4,211
| +77% | +$301K | 0.12% | 142 |
|
|
2018
Q2 | $352K | Sell |
5,468
-1,250
| -19% | -$82.4K | 0.06% | 239 |
|
|
2018
Q1 | $418K | Sell |
6,718
-67
| -1% | -$4.81K | 0.08% | 187 |
|
|
2017
Q4 | $492K | Sell |
6,785
-191
| -3% | -$13.9K | 0.1% | 169 |
|
|
2017
Q3 | $567K | Sell |
6,976
-259
| -4% | -$20.5K | 0.13% | 139 |
|
|
2017
Q2 | $582K | Hold |
7,235
| – | – | 0.14% | 143 |
|
|
2017
Q1 | $568K | Sell |
7,235
-137
| -2% | -$10.9K | 0.17% | 122 |
|
|
2016
Q4 | $582K | Sell |
7,372
-844
| -10% | -$68.3K | 0.19% | 104 |
|
|
2016
Q3 | $731K | Sell |
8,216
-93
| -1% | -$8.78K | 0.25% | 84 |
|
|
2016
Q2 | $796K | Buy |
8,309
+4
| +0% | +$399 | 0.27% | 76 |
|
|
2016
Q1 | $862K | Buy |
8,305
+466
| +6% | +$45.3K | 0.29% | 71 |
|
|
2015
Q4 | $766K | Buy |
7,839
+511
| +7% | +$50K | 0.26% | 68 |
|
|
2015
Q3 | $707K | Buy |
7,328
+96
| +1% | +$10.1K | 0.25% | 72 |
|
|
2015
Q2 | $758K | Buy |
7,232
+810
| +13% | +$82.8K | 0.25% | 77 |
|
|
2015
Q1 | $663K | Buy |
6,422
+531
| +9% | +$53.7K | 0.25% | 75 |
|
|
2014
Q4 | $567K | Buy |
5,891
+334
| +6% | +$29.4K | 0.22% | 84 |
|
|
2014
Q3 | $442K | Buy |
5,557
+2,466
| +80% | +$194K | 0.18% | 87 |
|
|
2014
Q2 | $233K | Buy |
3,091
+8
| +0.3% | +$605 | 0.1% | 143 |
|
|
2014
Q1 | $231K | Buy |
3,083
+169
| +6% | +$11.9K | 0.11% | 128 |
|
|
2013
Q4 | $209K | Buy |
+2,914
| New | +$187K | 0.1% | 143 |
|
Other funds holding CVS
Buckingham Strategic Wealth's CVS Position: Q2 2024 in Review
Buckingham Strategic Wealth increased its CVS Health (CVS) stake by 16% in Q2 2024, buying an estimated $122K and bringing the position to 13,824 shares worth $816K. The position accounts for 0.01% of the portfolio, ranked #371.
Buckingham Strategic Wealth first reported a position in CVS in Q4 2013 and has held it in 43 quarters since. The position peaked at $1.22M in Q4 2021. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.
- Buckingham Strategic Wealth held 13,824 shares of CVS Health worth $816K as of Q2 2024.
- Buckingham Strategic Wealth bought 1,954 CVS Health shares in Q2 2024, an estimated $122K.
- CVS Health made up 0.01% of Buckingham Strategic Wealth's portfolio in Q2 2024, its #371 holding.
- Buckingham Strategic Wealth first reported a position in CVS Health in Q4 2013 and has held it in 43 quarters since.
- Buckingham Strategic Wealth's CVS Health position peaked at $1.22M in Q4 2021.
- 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.
Based on Buckingham Strategic Wealth's 13F filing for Q2 2024, filed 12 Aug 2024.